tiprankstipranks
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market
FDMT
4D Molecular Therapeutics
RESEARCH TOOLSreports
Want to see FDMT full AI Analyst Report?

4D Molecular Therapeutics (FDMT) Stock News & Sentiment

518 Followers
Analyst Reiterates Buy on 4D Molecular Therapeutics as Wet AMD Gene Therapy Advances, Keeps $36 Price Target Unchanged
Premium
Ratings
Analyst Reiterates Buy on 4D Molecular Therapeutics as Wet AMD Gene Therapy Advances, Keeps $36 Price Target Unchanged
8d ago
FDMT
Daniel Giraldo Reiterates Buy on 4D Molecular Therapeutics, Citing Strong 4D-150 Progress and Undervalued Upside vs. $29 Price Target
Premium
Ratings
Daniel Giraldo Reiterates Buy on 4D Molecular Therapeutics, Citing Strong 4D-150 Progress and Undervalued Upside vs. $29 Price Target
9d ago
FDMT
4D Molecular Therapeutics Consolidates Financial Leadership Under New Role
Premium
Company Announcements
4D Molecular Therapeutics Consolidates Financial Leadership Under New Role
2M ago
8K
FDMT
Reimbursement and Pricing Pressures Threaten Commercial Outlook for 4D Molecular Therapeutics’ Gene Therapies
Premium
Company Announcements
Reimbursement and Pricing Pressures Threaten Commercial Outlook for 4D Molecular Therapeutics’ Gene Therapies
2M ago
FDMT
4D Molecular Therapeutics, Inc. (FDMT) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
4D Molecular Therapeutics, Inc. (FDMT) Q4 Earnings Cheat Sheet
3M ago
FDMT
4D Molecular Therapeutics Restructures Equity via Warrant Exchange
Premium
Company Announcements
4D Molecular Therapeutics Restructures Equity via Warrant Exchange
4M ago
8K
FDMT
4D Molecular Therapeutics Expands Leadership With New Director Appointment
Premium
Company Announcements
4D Molecular Therapeutics Expands Leadership With New Director Appointment
4M ago
8K
FDMT
More FDMT News >

FDMT News on the Web

4D Molecular Therapeutics Touts Rapid Phase 3 Momentum for Retinal Gene Therapy
MarketBeat
Bullish
4D Molecular Therapeutics Inc at Bank of America Global Healthcare Conference Transcript
GuruFocus News
Neutral
Analyst Reiterates Buy on 4D Molecular Therapeutics as Wet AMD Gene Therapy Advances, Keeps $36 Price Target Unchanged
TipRanks News
Bullish
Daniel Giraldo Reiterates Buy on 4D Molecular Therapeutics, Citing Strong 4D-150 Progress and Undervalued Upside vs. $29 Price Target
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Rockwell Med (RMTI), 4D Molecular Therapeutics (FDMT) and Cognition Therapeutics (CGTX)
TipRanks News
Bullish
RBC Capital Sticks to Their Buy Rating for 4D Molecular Therapeutics (FDMT)
TipRanks News
Bullish
4D Molecular price target lowered to $33 from $38 at Goldman Sachs
TipRanks News
Bullish
4D Molecular files $400M mixed securities shelf
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
FDMT
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.75 articles
News Sentiment
This Week100%
Sector Average79%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FDMT’s Media Buzz Sentiment?
2 articles about FDMT were published this week. In an average week, 1.75 articles are published.
    What is FDMT’s weekly average amount of articles?
    In an average week, 1.75 articles about FDMT are published.
      What is FDMT’s News Sentiment?
      100% of articles about FDMT were positive this week, compared to its sector average of 79%.
        Healthcare Stocks that are Trending in the News
        DOCSDoximity
        AVAHAveanna Healthcare Holdings
        AQSTAquestive Therapeutics
        GOSSGossamer Bio
        HTFLHeartFlow, Inc.
        Showing the stocks with the most bullish news sentiment over the past week